[Translation] A Phase 3, randomized, discontinuation, double-blind, placebo-controlled, multicenter, rescue-option relapse study to evaluate the efficacy and safety of PF-04965842 in patients with moderate to severe atopic dermatitis
此项研究旨在评估PF-04965842治疗12岁及以上成人和青少年中度至重度特应性皮炎(AD)患者的疗效和安全性,所得数据将用于支持临床注册。
[Translation] This study aims to evaluate the efficacy and safety of PF-04965842 in the treatment of moderate to severe atopic dermatitis (AD) in adults and adolescents aged 12 years and above. The data obtained will be used to support clinical registration.